The Response of Human Endometriotic Implants to the Anti-Progesterone Steroid R 2323
article
OA: closed
CC0
⤵ 11 in-corpus citations
AI-generated summary
This paper investigates the effect of the anti-progesterone steroid R 2323 on human endometriotic implants.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The histology and ultrastructure of small endometriotic lesions were studied in 19 patients before and after hormonal therapy with the anti-progesterone steroid R 2323 (Gestrinone). Histologic results demonstrate that treatment of endometriosis with this steroid does not result in complete elimination of the endometriotic foci, although glandular proliferation and secretion are arrested in most implants. The ultrastructural results indicate that this inhibition of proliferation and secretion is related to an enhanced activity of the lysosomal system in the epithelial cells of some endometriotic foci. In other implants, or even in other cells of the same foci, epithelial cells with only a small amount of supranuclear cytoplasm but lacking lysosomes may be found. The morphologic data demonstrate that the cellular involutionary response to the antiprogesterone drug Gestrinone involves an activation of the lysosomal system, an abortive apocrine secretion of cell remnants and finally, in some implants, an extrusion of individual epithelial cells. Since this involutionary process of endometriotic cells mimics the pre-menstrual lysosomal degradation in the endometrium, it is suggested that the competitive binding of the antiprogesterone Gestrinone to the progesterone receptors of endometriotic epithelium may cause a cellular progesterone withdrawal effect.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Endocrine dependency of endometriosis: an ultrastructural study via openalex
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
- Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone via openalex
- Ultrastructural changes in endometriotic implants during the menstrual cycle. via openalex
- Ultrastructural Changes in Endometriotic Tissue During Danazol Treatment via openalex
- Ultrastructural comparison of endometriotic implants and eutopic endometrium via openalex
- W2221233133 via openalex
- W2410955081 via openalex
- W127887556 via openalex
- W6716512485 via openalex
- W1529950036 via openalex
- W1988879990 via openalex
- W1996509481 via openalex
- W2035750052 via openalex
- W2079462003 via openalex
Cited by (11)
- THE ROLE OF MACROAUTOPHAGY IN THE PATHOGENESIS OF ENDOMETRIOSIS 2024
- The role of mesenchymal–epithelial transition in endometrial function 2018
- Epidemiology of Endometriosis 2003
- Biases in the endometriosis literature 1998
- The endometriotic implant 1991
- Therapie der Endometriose 1989
- Therapie der Endometriose 1989
- Erste klinische Erfahrungen bei der Behandlung der Endometriose mittels dem LH-RH-Analogon Zoladex Depot 1989
- THE RATIONALE FOR ENDOCRINE THERAPY 1989
- The morphologic effect of short-term medical therapy of endometriosis 1987
- Histology and ultrastructure of human endometriotic tissues treated with dydrogesterone (Duphaston) 1987
Source provenance
- europepmc
- last seen: 2026-09-16T06:11:32.772430+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:40.384591+00:00
- unpaywall
- last seen: 2026-09-15T06:33:26.365676+00:00
License: CC0
· commercial use OK